INTRODUCTION
The normal Factor VIII/von Willebrand factor (FVIII/ vWf)1 protein purified from normal plasma has been characterized as a macromolecular glycoprotein with two major biologic activities (1) (2) (3) . One activity, procoagulant activity, is related to the intrinsic phase of blood coagulation and is assayed by the specific ability to correct the blood coagulation defect in patients with hemophilia A. The second activity, von Willebrand factor activity, is assayed by the ability to induce agglutination or aggregation of von Willebrand's disease or normal platelets in the presence of ristocetin.
In hemophilia A (FVIII deficiency), procoagulant activity is deficient, whereas vWf activity is normal. In "classic" von Willebrand's disease both the procoagulant and vWf activity are decreased; however, recent studies have indicated that there are forms ofvon Willebrand's disease in which the vWf activity is the only activity that is decreased or it is more severely reduced than the procoagulant activity. Investigation of these patients has suggested that the reduced vWf activity is related to a deficiency of the carbohydrate moiety of this glycoprotein (4) (5) (6) . To (10) . The purified enzyme contained 270 U/ml. Proteolytic activity was assayed using a radiolabeled hemoglobin substrate (11) . Neither enzyme had measurable proteolytic activity. Sialic acid measurements were performed by the thiobarbiturate assay after hydrolysis in 0.1 N sulfuric acid at 80°C for 60 min (12) . Free sialic acid was measured in the same assay, however, the acid hydrolysis step was omitted. FVIII/vWf protein-neuraminidase-galactose oxidase) were simultaneously carried through identical experimental procedures. At specified time intervals, aliquots were removed and vWf and procoagulant activities were measured. A portion of each of the four incubation mixtures was chromatographed on Sepharose 4B. The fractions were collected and the protein and vWf activity were measured. The fractions with peak protein and vWf activity were pooled and the pH was adjusted to 7.4 with 0.5 N NaOH (added slowly with constant stirring). Then potassium borohydride was added at 100 iLg per milligram of protein, and the vWf and procoagulant activities were assayed. To insure that there was no nonspecific effect of potassium borohydride, all four incubation mixtures were again chromatographed over a Sepharose 4B column, and the FVIII/vWf protein was collected and assayed again. Protein concentration was estimated by the method of Lowry et al. (13) .
Assay procedures. FVIII procoagulant activity was measured as previously described (14) . vWf activity was assayed utilizing the washed formalin-fixed platelet method (15) . In all experiments, the modified FV1II/vWf protein was tested alone with appropriate controls at the same time intervals; in all assays, the test material was always diluted so that it fit in the middle of the standard curve.
RESULTS
The FVIII/vWf protein from the Sepharose 4B column revealed one band which did not enter a 5% polyacrylamide gel in the presence of sodium dodecyl sulfate and a single subunit of 230,000 mol wt. The mean specific vWf was 39.8 U/mg and procoagulant activity was 27.6 U/mg (pooled normal plasma equals 1 U/ml).
The sialic acid content of the FVIII/vWf protein revealed a mean value of 107.9+8.7 nM/mg (mean±l SD, n = 12) or 25 mol per 230,000-mol wt subunit. Determination of sialic acid in nine of these preparations by determining the free sialic acid after neuraminidase treatment revealed a value of 112.6± 10.3 nM/mg (meant 1 SD, n = 9) or 26 mol per 230,000-mol wt subunit. Despite removal of >95% (mean 96%, range 91-103%, n = 6) of sialic acid from the FVIII/vWf protein, no loss of vWf activity (98±4% of the control, n = 6) was observed and there was no alteration in procoagulant activity (101±5% of the control, n = 6) (Fig. 1) . When the FVIII/vWf protein was separated from the neuraminidase by rapid gel chromatography, the intact protein had identical vWf activity (units per milligram) to the control material or the material before separation of neuraminidase from the FVIII/vWf protein.
After desialyation of FVIII/vWf protein, the addition of galactose oxidase resulted in the rapid progressive loss of vWf activity. After a 3-h incubation, the vWf activity was decreased 50-63% (Fig. 1) and the procoagulant activity remained intact (99+4% of the control, n = 4). After a 20-h incubation, 90% of the vWf activity was destroyed compared to the controls (Table I) Experiments 1, 2, 3, and 4 each contained 0.75 mg/ml of purified human FVIII/vWf protein placed in the first incubation mixture with either buffer or neuraminidase (1/100 vol, final concentration of neuraminidase 0.05 U/ml) for 2 h. Free sialic acid was determined in all four mixtures. No free sialic acid was detected in the FVIII/vWf buffer mixtures whereas 96±+4% of sialic acid was removed in the neuraminidase mixtures. In the second incubation, galactose oxidase, 7 U/ml and horseradish peroxidase, 20 U/ml final concentration were added to mixtures 2 and 4 with an identical volume of buffer added to mixtures 1 and 3. The second incubation was performed for 20 h with samples removed at various times for assay ofvWfactivity. In all four experiments, the procoagulant FVIII activity remained constant throughout the incubation period.
any alteration of migration of the major protein band or any new bands in sodium dodecyl sulfate polyacrylamide gel electrophoresis after treatment with neuraminidase or galactose oxidase. DISCUSSION Studies on the removal of sialic acid and/or the modification of penultimate galactose indicate that neither has an effect on the procoagulant activity of the FVIII/ vWf protein. Similarly, vWf activity was unaffected by removal of >95% of the sialic acid; however, modification of the galactose residues of the asialo FVIII/ vWf protein resulted in a time-dependent loss of vWf activity. Over the course of 3 h, 50-63% of the vWf activity was lost, and after 20 h, 90% of the vWf activity was destroyed. An advantage of using galactose oxidase to modify the galactose residues is apparent in that, under appropriate conditions, the enzymatically produced 6-aldehydo reaction product can be reconverted to galactose by borohydride.
The sialic acid content in FVIII/vWf protein reported here is different from those previously reported by us and others. Marchesi et al. (7) reported -1% sialic acid, Legaz et al. (16) reported 1.2%, and we reported 1.5% (5) . Recently, Sodetz and co-workers (8) have reported -5% sialic acid content in the FVIII/vWf protein, and our data in this paper indicated approximately a 3.3% sialic acid content. The reasons for these discrepancies are not clear, but certainly different starting material, different purification procedures, and possible preselection of different subsets of FVIII/vWf molecules (i.e. subpopulations) may play a significant role in the reported variances of the sialic acid content. The results of Sodetz and co-workers (8) and ours cannot be explained on this basis, since we both used similar starting material and purification procedures. The possibility that our value is lower because we prepared a partially desialated FVIII/vWf protein would be one explanation. However, our final material had similar activities per milligrams of protein and it is clear from our studies that treatment of our FVIII/vWf protein with galactose oxidase has absolutely no effect on vWf activity unless that material is preincubated with neuraminidase to remove the sialic acid before exposure to galactose oxidase.
Several different groups have tested the effects of neuraminidase and(or) galactose oxidase treatment of FVIII/vWf protein on vWf activity (17) . In general, many of these studies have not demonstrated the relative purity of their FVIII/vWf protein preparation or of their enzyme preparations; and in some studies bovine FVIII, which does not require ristocetin, was tested rather than human material. In two studies in which vWf activity was decreased by neuraminidase treatment, although >80% sialic acid was removed, only 50% of activity was lost (8, 18) . In our studies, removal of >95% of the sialic acid did not affect vWf activity.
Our results indicate that the intact penultimate galactose residues are necessary for vWfactivity. After oxidation by galactose oxidase, >90% ofactivity is destroyed; and the addition of potassium borohydride results in the concommitant reduction of the aldehydo group and regeneration of vWf activity. These data strongly suggest the loss of vWf activity to be related to specific modification of the galactose residues. Conceivably, borohydride may affect other portions of the protein other than the oxidized galactose residues; however, intact FVIII/vWf protein did not lose activity when treated with galactose oxidase nor was it affected by subsequent incubation with borohydride. These studies confirm the identification of the intact galactose moiety as a critical determinant of vWf activity.
